We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
139 hedge funds and large institutions have $249M invested in Anavex Life Sciences in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 29 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
110% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 29
3.33% more ownership
Funds ownership: 31.28% → 34.61% (+3.3%)
1% less capital invested
Capital invested by funds: $252M → $249M (-$2.79M)
5% less funds holding
Funds holding: 147 → 139 (-8)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
39% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $28M
Holders
139
Holders Change
-8
Holders Change %
-5.44%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
61
Reduced
29
Closed
24
Calls
$17.1M
Puts
$28M
Net Calls
-$10.9M
Net Calls Change
-$3.44M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$15.5M |
| 2 |
Millennium Management
New York
|
+$6.73M |
| 3 |
Goldman Sachs
New York
|
+$4.2M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.85M |
| 5 |
BlackRock
New York
|
+$2.82M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$3.79M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.94M |
| 3 |
D.E. Shaw & Co
New York
|
-$2.76M |
| 4 |
Barclays
London,
United Kingdom
|
-$1.92M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
-$1.11M |
